by | Oct 14, 2022 | News
Rutgers researchers are seeking to develop the technology to modify or “edit” protein molecules in the body—an advance that could spur major breakthroughs in human health. While such research is in its early phases, the Rutgers team has received support from a... by | Oct 14, 2022 | News
Chronic sleep deprivation in a small group of healthy adults increased production of immune cells linked to inflammation while also altering the immune cells’ DNA, a new study found. “Not only were the number of immune cells elevated, but they may be wired and... by | Oct 13, 2022 | News
Innovation for Impact: Commercializing Academic Discovery The NJECC Annual Conference, Innovation for Impact: Commercializing Academic Discovery, is a statewide commercialization conference taking place on October 27th, 2022 at NJIT’s Campus Center in Newark,... by | Oct 13, 2022 | News
Please read Dr. Olfson’s article in the Journal of Substance Abuse Treatment titled, “Psychosocial and behavioral therapy in conjunction with medication for opioid use disorder: Patterns, predictors, and association with buprenorphine treatment... by | Oct 13, 2022 | News
Is it ethical to test possible HIV cures by having subjects stop taking antiretroviral therapy and then giving them placebos rather than the experimental treatment? The answer is often yes, according to a new paper published in the Journal of Virus Eradication by...